PICCO, AGNESE
 Distribuzione geografica
Continente #
EU - Europa 6.802
AS - Asia 298
SA - Sud America 30
NA - Nord America 25
AF - Africa 9
OC - Oceania 1
Totale 7.165
Nazione #
IT - Italia 6.791
SG - Singapore 128
CN - Cina 76
VN - Vietnam 73
US - Stati Uniti d'America 20
BR - Brasile 16
AR - Argentina 10
ID - Indonesia 7
NL - Olanda 4
IQ - Iraq 3
TW - Taiwan 3
HK - Hong Kong 2
IN - India 2
MA - Marocco 2
MX - Messico 2
PY - Paraguay 2
RU - Federazione Russa 2
ZA - Sudafrica 2
BO - Bolivia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
FI - Finlandia 1
GB - Regno Unito 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
MY - Malesia 1
NC - Nuova Caledonia 1
SE - Svezia 1
SV - El Salvador 1
TN - Tunisia 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 7.165
Città #
Genova 3.971
Genoa 1.668
Rapallo 661
Vado Ligure 467
Singapore 43
Beijing 38
Ho Chi Minh City 33
Bordighera 17
Hanoi 16
Ashburn 13
Rome 5
Biên Hòa 4
Da Nang 4
Oegstgeest 4
Tianjin 4
Cantalupo Ligure 2
Ciudad del Este 2
Hong Kong 2
Hải Dương 2
Mexico City 2
Ninh Bình 2
San Jose 2
Addis Ababa 1
Ahmedabad 1
Aïn Oussera 1
Bananal 1
Bandung 1
Bangkinang 1
Barueri 1
Bogotá 1
Bắc Ninh 1
Capão do Cipó 1
Casablanca 1
Castries 1
Chennai 1
Cotia 1
Cuiabá 1
Córdoba 1
Denpasar 1
Erbil 1
Florianópolis 1
Foshan 1
Gansbaai 1
General La Madrid 1
Haiphong 1
Harare 1
Itumbiara 1
Jaboatão dos Guararapes 1
José C. Paz 1
La Paz 1
Lappeenranta 1
Lavras 1
Los Angeles 1
Malang 1
Mariluz 1
Marrakesh 1
Mendoza 1
Nairobi 1
Noumea 1
Orem 1
Osasco 1
Penza 1
Ponte Alta do Bom Jesus 1
Poplar 1
Posadas 1
Prague 1
Quilmes 1
Registro 1
Saldanha 1
Salta 1
Salto 1
San Miguel 1
San Salvador 1
Santa Clara 1
Santana do Livramento 1
Semarang 1
Stockholm 1
São José do Rio Preto 1
Taipei 1
Tashkent 1
Thái Bình 1
Thái Nguyên 1
Tigre 1
Tokyo 1
Tunis 1
Vinnytsia 1
Vũng Tàu 1
Totale 7.027
Nome #
A normative study of the Italian printed word version of the free and cued selective reminding test 209
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 197
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 188
Amyloid positron emission tomography and cognitive reserve. 179
Neuroimaging findings in mild cognitive impairment 177
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 166
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort 165
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 163
Parkinson’s Disease Sleep Scale 2: application in an Italian population 160
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 160
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 156
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 154
What predicts cognitive decline in de novo Parkinson's disease? 152
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 150
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 149
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 145
The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study 144
Early identification of MCI converting to AD: a FDG PET study 143
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 140
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 139
The role of the serotonergic system in REM sleep behavior disorder 137
Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 137
Functional imaging in pre-motor Parkinson's disease 134
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 133
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 133
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 131
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 130
Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy. 129
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 124
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 123
Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study 122
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 122
Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework 120
Cortical structural covariance of nigro.striatal degeneration in dementia with Lewy bodies 119
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 117
Biomarkers validation in Alzheimer’s Disease and related pathologies 116
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework 114
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 112
Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly 109
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 108
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers 107
Neuroimaging Findings in Mild Cognitive Impairment 107
Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study 105
Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects 104
Amygdalar nuclei and hippocampal subfields on MRI: test-retest reliability of automated volumetry across different MRI sites and vendors 103
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 99
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 97
Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques 95
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 94
Orbitofrontal (18) F-DOPA Uptake and Movement Preparation in Parkinson's Disease. 94
Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease 84
Studio dell’attività serotoninergica troncoencefalica nel disturbo comportamentale del sonno REM. 80
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 78
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 77
Resting metabolic connectivity in Alzheimer's disease 74
null 70
White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 64
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF RESILIENCE SCALE IN ADULTS AND ELDERLY HEALTHY SUBJECTS 47
Totale 7.285
Categoria #
all - tutte 24.999
article - articoli 21.808
book - libri 0
conference - conferenze 1.851
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 977
Totale 49.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 29 35 53 43 69 53 46
2021/2022703 23 20 52 81 23 67 31 167 50 62 22 105
2022/2023753 62 62 14 83 106 121 0 64 126 11 98 6
2023/2024422 20 42 8 59 39 88 18 37 19 5 19 68
2024/20251.130 35 79 18 78 162 131 107 169 54 48 109 140
2025/2026897 287 46 93 140 293 38 0 0 0 0 0 0
Totale 7.285